The main pathways of enrichment included PI3K-Akt signaling pathway, EGFR tyrosine kinase inhibitor resistance, apoptosis, prostate cancer, proteoglycans in cancer as well as Alzheimer disease. Here, PIK3CA is linked to prostate carcinoma.